World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
83
Citations
20973
World Ranking
1013
National Ranking
464

Ana Espinel-Ingroff publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Ana Espinel-Ingroff sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 205 publications — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Ana Espinel-Ingroff D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Ana Espinel-Ingroff sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 83 D-Index — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Ana Espinel-Ingroff is affiliated with Virginia Commonwealth University Medical Center in the United States. Their research primarily focuses on the field of medicine, with significant contributions to epidemiology, infectious diseases, cell biology, plant science, and molecular biology. The scientist's work centers around topics such as antifungal resistance and susceptibility, fungal infections and studies, nail diseases and treatments, plant pathogens and fungal diseases, mycotoxins in agriculture and food, as well as fungal and yeast genetics research.

They have published extensively in various scientific venues, with the most frequent publications appearing in:

  • Journal of Fungi (6 publications)
  • Pathogens (1 publication)
  • Antimicrobial Agents and Chemotherapy (1 publication)
  • Current Fungal Infection Reports (1 publication)

Recent notable papers authored or coauthored by Ana Espinel-Ingroff include:

  • "Antifungal Resistance among Less Prevalent Candida Non-albicans and Other Yeasts versus Established and under Development Agents: A Literature Review," 2021, Journal of Fungi
  • "Antifungal Resistance in Cryptococcal Infections," 2024, Pathogens
  • "Etest ECVs/ECOFFs for Detection of Resistance in Prevalent and Three Nonprevalent Candida spp. to Triazoles and Amphotericin B and Aspergillus spp. to Caspofungin: Further Assessment of Modal Variability," 2021, Antimicrobial Agents and Chemotherapy
  • "Commercial Methods for Antifungal Susceptibility Testing of Yeasts: Strengths and Limitations as Predictors of Resistance," 2022, Journal of Fungi
  • "A Mini-Review of In Vitro Data for Candida Species, Including C. auris, Isolated during Clinical Trials of Three New Antifungals: Fosmanogepix, Ibrexafungerp, and Rezafungin," 2024, Journal of Fungi

The frequent co-authors working with Ana Espinel-Ingroff include Rafael Cantón, Éric Dannaoui, Márcia de Souza Carvalho Melhem, Diniz Pereira Leite Júnior, and Juliana Possatto Fernandes Takahashi. The collaboration with these co-authors spans various aspects of antifungal research and susceptibility testing.

Their research extensively addresses antifungal resistance and susceptibility, encompassing both common and less prevalent Candida species and other yeasts. This includes evaluating methods for antifungal susceptibility testing, resistance detection in fungal pathogens, and reviews of antifungal agents currently established or under development.

The scientific work by Ana Espinel-Ingroff contributes to understanding fungal infections and resistance mechanisms, including studies on nail diseases and the impact of fungal pathogens on plant health and mycotoxin presence in agriculture and food. The diversity of research topics reflects a multidisciplinary approach within the overarching medical and biological sciences fields.

Best Publications

  • Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections

    John H. Rex;Michael A. Pfaller;John N. Galgiani;Marilyn S. Bartlett

  • Voriconazole Treatment for Less-Common, Emerging, or Refractory Fungal Infections

    John R. Perfect;Kieren A. Marr;Thomas J. Walsh;Richard N. Greenberg

  • Comparison of In Vitro Activities of the New Triazole SCH56592 and the Echinocandins MK-0991 (L-743,872) and LY303366 against Opportunistic Filamentous and Dimorphic Fungi and Yeasts

    Ana Espinel-Ingroff

  • Antifungal Susceptibility Testing: Practical Aspects and Current Challenges

    John H. Rex;Michael A. Pfaller;Thomas J. Walsh;Vishnu Chaturvedi

  • In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens

    Ana Espinel-Ingroff

  • Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: Time for harmonization of CLSI and EUCAST broth microdilution methods

    M.A. Pfaller;D. Andes;D.J. Diekema;A. Espinel-Ingroff

  • In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi

    Ana Espinel-Ingroff

  • Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi.

    A Espinel-Ingroff;K Dawson;M Pfaller;E Anaissie

  • In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature.

    Ana Espinel-Ingroff;Kathleen Boyle;Daniel J. Sheehan

  • Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests.

    A Espinel-Ingroff;C W Kish;T M Kerkering;R A Fromtling

  • Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints

    M. A. Pfaller;D. J. Diekema;J. H. Rex;A. Espinel-Ingroff

  • In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.

    Ana Espinel-Ingroff

  • Quality Control Limits for Broth Microdilution Susceptibility Tests of Ten Antifungal Agents

    A. L. Barry;M. A. Pfaller;S. D. Brown;A. Espinel-Ingroff

  • Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts.

    R A Fromtling;J N Galgiani;M A Pfaller;A Espinel-Ingroff

  • Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi.

    A. Espinel-Ingroff;M. Bartlett;R. Bowden;N. X. Chin

  • Testing Conditions for Determination of Minimum Fungicidal Concentrations of New and Established Antifungal Agents for Aspergillus spp.: NCCLS Collaborative Study

    A. Espinel-Ingroff;A. Fothergill;J. Peter;M. G. Rinaldi

  • Collaborative investigation of variables in susceptibility testing of yeasts.

    M A Pfaller;M G Rinaldi;J N Galgiani;M S Bartlett

  • Comparison of the E-test with the NCCLS M38-P Method for Antifungal Susceptibility Testing of Common and Emerging Pathogenic Filamentous Fungi

    Unknown

  • Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Triazoles and Six Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)

    A. Espinel-Ingroff;D. J. Diekema;A. Fothergill;Elizabeth Johnson

  • Optimizing the Correlation between Results of Testing In Vitro and Therapeutic Outcome In Vivo for Fluconazole by Testing Critical Isolates in a Murine Model of Invasive Candidiasis

    John H. Rex;Page W. Nelson;Victor L. Paetznick;Mario Lozano-Chiu

  • Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole

    A. Espinel-Ingroff;A.I. Aller;E. Canton;L.R. Castanon-Olivares

  • Antifungal Susceptibility Testing of Filamentous Fungi

    Ana Espinel-Ingroff;Emilia Cantón;Javier Pemán

Frequent Co-Authors

Javier Pemán
Javier Pemán Hospital Universitari i Politècnic La Fe
Michael A. Pfaller
Michael A. Pfaller JMI Laboratories
John D. Turnidge
John D. Turnidge University of Adelaide
Mahmoud A. Ghannoum
Mahmoud A. Ghannoum Case Western Reserve University
Michael G. Rinaldi
Michael G. Rinaldi The University of Texas Health Science Center at San Antonio
Teresa Peláez
Teresa Peláez Hospital General Universitario Gregorio Marañón
Jacques F. Meis
Jacques F. Meis Canisius-Wilhelmina Ziekenhuis
Manuel Cuenca-Estrella
Manuel Cuenca-Estrella Instituto de Salud Carlos III
Thomas J. Walsh
Thomas J. Walsh Weill Cornell Medicine
Josep Guarro
Josep Guarro Rovira i Virgili University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens various career avenues, but it's also valuable to consider related online degrees that can complement or diversify your skill set. For instance, healthcare fields like becoming a child life specialist salary with bachelor degree offer meaningful work with a strong salary outlook, often accessible with a relevant undergraduate degree.

For individuals facing unique challenges, such as a criminal record, it’s encouraging to know there are online colleges that accept felons. These programs provide opportunities for second chances and can lead to rewarding careers within or outside microbiology.

Exploring healthcare options further, pursuing a path toward becoming a functional medicine nurse salary can be lucrative and impactful. Such specialized nursing roles often integrate biological sciences, making microbiology knowledge beneficial.

Finally, careers in health information management, like obtaining a certified professional coder certification, offer stable employment with growth potential. This certification aligns with microbiology graduates interested in medical billing, coding, and healthcare administration.

Best Scientists Citing Ana Espinel-Ingroff

Trending Scientists

Recently Published Articles